US equities |
META $625.17 ▼-0.85% TSLA $405.93 ▲+3.65% MU $933.02 ▲+3.24% NVDA $218.86 ▲+1.32% SPCX $151.16 ▲+2.90% AMD $560.26 ▲+5.45% SNDK $1,306.31 ▲+4.04% INTC $94.23 ▲+4.16%
FinancialContent

Schrodinger, Inc. - Common Stock (NQ:SDGR)

26.90 +2.40 (+9.80%)
Delayed Quote Updated: 12:07 PM EDT, Oct 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Schrodinger, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
Schrödinger to Present at Jefferies Global Healthcare Conference
From Schrödinger
Via Business Wire
News headline image
Schrödinger Announces CFO Appointment
From Schrödinger
Via Business Wire
News headline image
Earnings Scheduled For May 7, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 26, 2025 ↗
 
Via Benzinga
News headline image
Schrödinger to Present Phase 1 Clinical Data on MALT1 Inhibitor SGR-1505 at EHA Annual Congress and International Conference on Malignant Lymphoma
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Strong First Quarter 2025 Financial Results
From Schrödinger
Via Business Wire
News headline image
Schrödinger to Present at BofA Securities 2025 Healthcare Conference
From Schrödinger
Via Business Wire
News headline image
Schrödinger Presents New Preclinical Data at AACR Annual Meeting
From Schrödinger
Via Business Wire
News headline image
Schrödinger to Announce First Quarter 2025 Financial Results on May 7
From Schrödinger
Via Business Wire
News headline image
3 Momentum Stocks That Could Soar Post-Market Volatility
Three unexpected companies have rallied quickly in the period following tariff-related market turbulence; can they maintain momentum? 
Via MarketBeat
Topics Artificial Intelligence World Trade
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
Schrödinger’s Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
From Schrödinger
Via Business Wire
News headline image
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing ↗
FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods. 
Via Benzinga
Topics Animal Testing
News headline image
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Wondering what's happening in today's after-hours session? ↗
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
News headline image
Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements ↗
Several stocks in the health care technology space are moving higher after the market close on Thursday after the U.S. Food and Drug Administration (FDA) announced plans to phase out animal testing... 
Via Benzinga
Topics Animal Testing
News headline image
Schrödinger to Present Preclinical Data at AACR Annual Meeting
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
Schrödinger Expands Board of Directors with Appointment of Bridget van Kralingen
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Strong Fourth Quarter and Full-Year 2024 Financial Results
From Schrödinger
Via Business Wire
News headline image
Schrödinger to Participate in Upcoming Investor Conferences
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
Schrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26
From Schrödinger
Via Business Wire
News headline image
AI Pharma: 2 Paths to AI-Powered Drug Investment
AI is transforming drug development, allowing companies to identify new drug targets, optimize clinical trials and speed delivery of medicines to patients. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Seagate Posts Upbeat Earnings, Joins Netflix, Travelers, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities
From Schrödinger
Via Business Wire
News headline image
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
News headline image
Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference
From Schrödinger
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >